fda compounding glp 1 π¨ Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these FDA's compounded GLP-1 limits will
Description
doi: 10.1177/20420188231222367 11 MadsenMSAHolmJBPallejAWismannPFabriciusKRigboltKet al
Our infographic details what to watch out for and when to consult your clinician

Canadian Association for Suicide Prevention: Find a 24-hour crisis centre

Tirzepatide associated with reduced albuminuria in participants with type 2 diabetes: pooled post hoc analysis from the randomized active- and placebo-controlled SURPASS-1-5 clinical trials

Educational live streams 5x a week that cover a wide variety of topics from nutrition to training and supplementation
